Kim Young Eun, Jeon Beom S, Paek Sun-Ha, Yun Ji Young, Yang Hui-Jun, Kim Han-Joon, Ehm Gwanhee, Kim Hee Jin, Lee Jee-Young, Kim Ji-Young
Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea; Parkinson's Disease Study Group, Seoul National University Hospital, Seoul, Republic of Korea.
Parkinson's Disease Study Group, Seoul National University Hospital, Seoul, Republic of Korea; Department of Neurology and Movement Disorder Center, Seoul National University Hospital, Seoul, Republic of Korea.
J Clin Neurosci. 2015 Feb;22(2):315-9. doi: 10.1016/j.jocn.2014.07.016. Epub 2014 Oct 28.
The effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease (PD) is not well known. We evaluated the change in the incidence of probable RBD after bilateral STN DBS in PD patients. Ninety patients with PD treated with bilateral STN DBS underwent retrospective assessment of RBD by interview before and after DBS. Forty-seven (52.2%) of the 90 patients had RBD preoperatively. RBD was resolved only in one patient and persisted in 46 patients at 1 year after DBS. RBD developed de novo in 16 patients (de novo RBD group) within 1 year after DBS, resulting in 62 (68.9%) of the 90 patients having RBD 1 year after DBS. Patients with RBD at any time within 1 year after DBS (RBD group, n = 63) were older than the patients without RBD (non-RBD group, n = 27). The sum of the Unified Parkinson Disease Rating Scale (UPDRS) axial score for the "on" state was lower in the RBD group than in the non-RBD group after DBS (p = 0.029). Comparing the de novo RBD group and non-RBD group, the UPDRS Part III and total score and the levodopa equivalent daily doses for the "on" states decreased more in the de novo RBD group than in the non-RBD group (p < 0.05). The incidence of clinical RBD increased after bilateral STN DBS because de novo RBD developed and pre-existing RBD persisted after DBS.
丘脑底核(STN)深部脑刺激(DBS)对帕金森病(PD)患者快速眼动睡眠行为障碍(RBD)的影响尚不清楚。我们评估了PD患者双侧STN DBS术后可能发生RBD的发生率变化。90例接受双侧STN DBS治疗的PD患者在DBS前后通过访谈对RBD进行了回顾性评估。90例患者中有47例(52.2%)术前存在RBD。DBS术后1年,仅1例患者的RBD得到缓解,46例患者的RBD持续存在。16例患者(新发RBD组)在DBS术后1年内新发RBD,导致90例患者中有62例(68.9%)在DBS术后1年出现RBD。DBS术后1年内任何时间出现RBD的患者(RBD组,n = 63)比未出现RBD的患者(非RBD组,n = 27)年龄更大。DBS术后,RBD组“开”状态下统一帕金森病评定量表(UPDRS)轴向评分总和低于非RBD组(p = 0.029)。比较新发RBD组和非RBD组,新发RBD组“开”状态下UPDRS第三部分及总分和左旋多巴等效日剂量的下降幅度大于非RBD组(p < 0.05)。双侧STN DBS术后临床RBD的发生率增加,因为术后出现了新发RBD且既往存在的RBD持续存在。